MYEMI INCORPORATED – Trademark Portfolio
Entity Type: 03
MYEMI INCORPORATED owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as IMONEOF, ONEOF THEM", MYEMI INCORPORATED, IMONEOF COLLECTIONZ, and MYEMI INTERTAINMENT. Of these, 7 are registered and 4 are pending. The portfolio spans 4 Nice Classification classes, led by Class 25 (Clothing) and Class 35 (Advertising & Business). Headquartered in LANSING, MI.
4263 BARTON RD
LANSING, MI 48917
Showing of trademarks Trademarks
Trademark Classifications
MYEMI INCORPORATED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does MYEMI INCORPORATED have?
MYEMI INCORPORATED has 13 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 pending, 2 abandoned.
What trademark classes does MYEMI INCORPORATED file in?
MYEMI INCORPORATED files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 9 (Computers & Electronics). Class 25 covers clothing, footwear, headgear.
What are MYEMI INCORPORATED's most well-known trademarks?
MYEMI INCORPORATED's registered trademark portfolio includes well-known marks such as IMONEOF, ONEOF THEM", MYEMI INCORPORATED, IMONEOF COLLECTIONZ, and MYEMI INTERTAINMENT. These are among 7 currently registered trademarks in the portfolio.
What is MYEMI INCORPORATED's trademark registration success rate?
MYEMI INCORPORATED has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 4 applications are pending review.